Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: KBV Research | PRODUCT CODE: 1093282

Cover Image

PUBLISHER: KBV Research | PRODUCT CODE: 1093282

LAMEA Diabetes Care Devices Market Size, Share & Industry Trends Analysis Report By Product (Insulin Delivery Devices and Blood Glucose Monitoring Devices), By Country and Growth Forecast, 2022 - 2028

PUBLISHED:
PAGES: 82 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 1500
PDF (Site License)
USD 1800
PDF (Enterprisewide License)
USD 2520

Add to Cart

The Latin America, Middle East and Africa Diabetes Care Devices Market would witness market growth of 7.6% CAGR during the forecast period (2022-2028).

An increase in the incidence of diabetes, as well as changes in urbanization and sedentary lifestyle, is driving the diabetes care devices market growth. Furthermore, technical improvements in the field of diabetes devices, an increase in the diabetic population around the world, an increase in the demand for fast and safe diagnoses, and a rise in diabetes therapies would drive the diabetes care market in the coming years.

A significant prevalence of the geriatric population, economical healthcare facilities, cost-effective labor, and relatively lax regulatory laws are all driving diabetic device manufacturers to expand their operations. To acquire maximum market share, manufacturers are now focusing on maximizing prospects in developing economies. The advent of high-end insulin pumps and pens, as well as technological developments in diabetic devices, are driving demand for these items. To capture a significant portion of the market, leading manufacturers are focused on technological advances and the creation of innovative products.

There is a significant number of people with obesity in this region. According to the National Library of Medicine, obesity rates among adolescents and children in Gulf countries range from 5% to 14% for men and 3% to 18% for females. Obesity is on the rise in the Gulf region, with prevalence rates ranging from 2% to 55% in adult females and 1% to 30% in adult males. Obesity in the UAE is twice as high as the global norm, In Kuwait, more than half of the adult population has diabetes connected to obesity, and 75% of Egyptians are overweight owing to the desert climate. Obesity rates have been rising in the Middle East and North Africa due to poor urban design, cultural issues (behavioral standards, both indoors and outdoors), unhealthy food habits, and other causes.

The Brazil market dominated the LAMEA Diabetes Care Devices Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $495.4 Million by 2028. The Argentina market is experiencing a CAGR of 8.2% during (2022 - 2028). Additionally, The UAE market would exhibit a CAGR of 7.3% during (2022 - 2028).

Based on Product, the market is segmented into Insulin Delivery Devices and Blood Glucose Monitoring Devices. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include F. Hoffmann-La Roche Ltd., DexCom, Inc., Novo Nordisk A/S, Sanofi S.A., Zealand Pharma A/S, B. Braun Melsungen AG, Bayer AG, Abbott Laboratories, Ypsomed AG, Arkray, Inc.

Scope of the Study

Market Segments covered in the Report:

By Product

  • Insulin Delivery Devices and
  • Blood Glucose Monitoring Devices

By Country

  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Companies Profiled

  • F. Hoffmann-La Roche Ltd.
  • DexCom, Inc.
  • Novo Nordisk A/S
  • Sanofi S.A.
  • Zealand Pharma A/S
  • B. Braun Melsungen AG
  • Bayer AG
  • Abbott Laboratories
  • Ypsomed AG
  • Arkray, Inc.

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 LAMEA Diabetes Care Devices Market, by Product
    • 1.4.2 LAMEA Diabetes Care Devices Market, by Country
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
      • 2.1.1.1 Market Composition and Scenario
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints

Chapter 3. Competition Analysis - Global

  • 3.1 KBV Cardinal Matrix
  • 3.2 Recent Industry Wide Strategic Developments
    • 3.2.1 Partnerships, Collaborations and Agreements
    • 3.2.2 Product Launches and Product Expansions
    • 3.2.3 Acquisition and Mergers
    • 3.2.4 Geographical Expansions
    • 3.2.5 Approvals and Trials
  • 3.3 Top Winning Strategies
    • 3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
    • 3.3.2 Key Strategic Move: (Partnerships, Collaborations and Agreements : 2018, Oct - 2022, May) Leading Players

Chapter 4. LAMEA Diabetes Care Devices Market by Product

  • 4.1 LAMEA Insulin Delivery Devices Market by Country
  • 4.2 LAMEA Blood Glucose Monitoring Devices Market by Country

Chapter 5. LAMEA Diabetes Care Devices Market by Country

  • 5.1 Brazil Diabetes Care Devices Market
    • 5.1.1 Brazil Diabetes Care Devices Market by Product
  • 5.2 Argentina Diabetes Care Devices Market
    • 5.2.1 Argentina Diabetes Care Devices Market by Product
  • 5.3 UAE Diabetes Care Devices Market
    • 5.3.1 UAE Diabetes Care Devices Market by Product
  • 5.4 Saudi Arabia Diabetes Care Devices Market
    • 5.4.1 Saudi Arabia Diabetes Care Devices Market by Product
  • 5.5 South Africa Diabetes Care Devices Market
    • 5.5.1 South Africa Diabetes Care Devices Market by Product
  • 5.6 Nigeria Diabetes Care Devices Market
    • 5.6.1 Nigeria Diabetes Care Devices Market by Product
  • 5.7 Rest of LAMEA Diabetes Care Devices Market
    • 5.7.1 Rest of LAMEA Diabetes Care Devices Market by Product

Chapter 6. Company Profiles

  • 6.1 F. Hoffmann-La Roche Ltd.
    • 6.1.1 Company Overview
    • 6.1.2 Financial Analysis
    • 6.1.3 Segmental and Regional Analysis
    • 6.1.4 Research & Development Expense
    • 6.1.5 Recent strategies and developments:
      • 6.1.5.1 Partnerships, Collaborations, and Agreements:
      • 6.1.5.2 Product Launches and Product Expansions:
  • 6.2 DexCom, Inc.
    • 6.2.1 Company Overview
    • 6.2.2 Financial Analysis
    • 6.2.3 Regional Analysis
    • 6.2.4 Research & Development Expenses
    • 6.2.5 Recent strategies and developments:
      • 6.2.5.1 Partnerships, Collaborations, and Agreements:
      • 6.2.5.2 Product Launches and Product Expansions:
      • 6.2.5.3 Acquisition and Mergers:
  • 6.3 Novo Nordisk A/S
    • 6.3.1 Company Overview
    • 6.3.2 Financial Analysis
    • 6.3.3 Segmental & Regional Analysis
    • 6.3.4 Research & Development Expenses
    • 6.3.5 Recent strategies and developments:
      • 6.3.5.1 Partnerships, Collaborations, and Agreements:
      • 6.3.5.2 Acquisition and Mergers:
  • 6.4 Sanofi S.A.
    • 6.4.1 Company Overview
    • 6.4.2 Financial Analysis
    • 6.4.3 Segmental and Regional Analysis
    • 6.4.4 Research & Development Expense
    • 6.4.5 Recent strategies and developments:
      • 6.4.5.1 Partnerships, Collaborations, and Agreements:
      • 6.4.5.2 Product Launches and Product Expansions:
  • 6.5 Zealand Pharma A/S (Valeritas, Inc.)
    • 6.5.1 Company Overview
    • 6.5.2 Financial Analysis
    • 6.5.3 Research & Development Expenses
    • 6.5.4 Recent strategies and developments:
      • 6.5.4.1 Product Launches and Product Expansions:
      • 6.5.4.2 Approvals and Trials:
  • 6.6 B. Braun Melsungen AG
    • 6.6.1 Company Overview
    • 6.6.2 Financial Analysis
    • 6.6.3 Segmental and Regional Analysis
    • 6.6.4 Research & Development Expenses
    • 6.6.5 Recent strategies and developments:
      • 6.6.5.1 Partnerships, Collaborations, and Agreements:
  • 6.7 Bayer AG
    • 6.7.1 Company Overview
    • 6.7.2 Financial Analysis
    • 6.7.3 Segmental and Regional Analysis
    • 6.7.4 Research & Development Expense
    • 6.7.5 Recent strategies and developments:
      • 6.7.5.1 Partnerships, Collaborations, and Agreements:
      • 6.7.5.2 Approvals:
  • 6.8 Abbott Laboratories
    • 6.8.1 Company Overview
    • 6.8.2 Financial Analysis
    • 6.8.3 Segmental and Regional Analysis
    • 6.8.4 Research & Development Expense
    • 6.8.5 Recent strategies and developments:
      • 6.8.5.1 Partnerships, Collaborations, and Agreements:
      • 6.8.5.2 Approvals:
  • 6.9 Ypsomed AG
    • 6.9.1 Company Overview
    • 6.9.2 Financial Analysis
    • 6.9.3 Segmental and Regional Analysis
    • 6.9.4 Recent strategies and developments:
      • 6.9.4.1 Partnerships, Collaborations, and Agreements:
  • 6.10. Arkray, Inc.
    • 6.10.1 Company Overview
    • 6.10.2 Recent strategies and developments:
      • 6.10.2.1 Partnerships, Collaborations, and Agreements:
      • 6.10.2.2 Geographical Expansions:

LIST OF TABLES

  • TABLE 1 LAMEA Diabetes Care Devices Market, 2018 - 2021, USD Million
  • TABLE 2 LAMEA Diabetes Care Devices Market, 2022 - 2028, USD Million
  • TABLE 3 Partnerships, Collaborations and Agreements- Diabetes Care Devices Market
  • TABLE 4 Product Launches And Product Expansions- Diabetes Care Devices Market
  • TABLE 5 Acquisition and Mergers- Diabetes Care Devices Market
  • TABLE 6 Geographical expansion- Diabetes Care Devices Market
  • TABLE 7 Approvals and Trials- Diabetes Care Devices Market
  • TABLE 8 LAMEA Diabetes Care Devices Market by Product, 2018 - 2021, USD Million
  • TABLE 9 LAMEA Diabetes Care Devices Market by Product, 2022 - 2028, USD Million
  • TABLE 10 LAMEA Insulin Delivery Devices Market by Country, 2018 - 2021, USD Million
  • TABLE 11 LAMEA Insulin Delivery Devices Market by Country, 2022 - 2028, USD Million
  • TABLE 12 LAMEA Blood Glucose Monitoring Devices Market by Country, 2018 - 2021, USD Million
  • TABLE 13 LAMEA Blood Glucose Monitoring Devices Market by Country, 2022 - 2028, USD Million
  • TABLE 14 LAMEA Diabetes Care Devices Market by Country, 2018 - 2021, USD Million
  • TABLE 15 LAMEA Diabetes Care Devices Market by Country, 2022 - 2028, USD Million
  • TABLE 16 Brazil Diabetes Care Devices Market, 2018 - 2021, USD Million
  • TABLE 17 Brazil Diabetes Care Devices Market, 2022 - 2028, USD Million
  • TABLE 18 Brazil Diabetes Care Devices Market by Product, 2018 - 2021, USD Million
  • TABLE 19 Brazil Diabetes Care Devices Market by Product, 2022 - 2028, USD Million
  • TABLE 20 Argentina Diabetes Care Devices Market, 2018 - 2021, USD Million
  • TABLE 21 Argentina Diabetes Care Devices Market, 2022 - 2028, USD Million
  • TABLE 22 Argentina Diabetes Care Devices Market by Product, 2018 - 2021, USD Million
  • TABLE 23 Argentina Diabetes Care Devices Market by Product, 2022 - 2028, USD Million
  • TABLE 24 UAE Diabetes Care Devices Market, 2018 - 2021, USD Million
  • TABLE 25 UAE Diabetes Care Devices Market, 2022 - 2028, USD Million
  • TABLE 26 UAE Diabetes Care Devices Market by Product, 2018 - 2021, USD Million
  • TABLE 27 UAE Diabetes Care Devices Market by Product, 2022 - 2028, USD Million
  • TABLE 28 Saudi Arabia Diabetes Care Devices Market, 2018 - 2021, USD Million
  • TABLE 29 Saudi Arabia Diabetes Care Devices Market, 2022 - 2028, USD Million
  • TABLE 30 Saudi Arabia Diabetes Care Devices Market by Product, 2018 - 2021, USD Million
  • TABLE 31 Saudi Arabia Diabetes Care Devices Market by Product, 2022 - 2028, USD Million
  • TABLE 32 South Africa Diabetes Care Devices Market, 2018 - 2021, USD Million
  • TABLE 33 South Africa Diabetes Care Devices Market, 2022 - 2028, USD Million
  • TABLE 34 South Africa Diabetes Care Devices Market by Product, 2018 - 2021, USD Million
  • TABLE 35 South Africa Diabetes Care Devices Market by Product, 2022 - 2028, USD Million
  • TABLE 36 Nigeria Diabetes Care Devices Market, 2018 - 2021, USD Million
  • TABLE 37 Nigeria Diabetes Care Devices Market, 2022 - 2028, USD Million
  • TABLE 38 Nigeria Diabetes Care Devices Market by Product, 2018 - 2021, USD Million
  • TABLE 39 Nigeria Diabetes Care Devices Market by Product, 2022 - 2028, USD Million
  • TABLE 40 Rest of LAMEA Diabetes Care Devices Market, 2018 - 2021, USD Million
  • TABLE 41 Rest of LAMEA Diabetes Care Devices Market, 2022 - 2028, USD Million
  • TABLE 42 Rest of LAMEA Diabetes Care Devices Market by Product, 2018 - 2021, USD Million
  • TABLE 43 Rest of LAMEA Diabetes Care Devices Market by Product, 2022 - 2028, USD Million
  • TABLE 44 KEY INFORMATION - F. HOFFMANN-LA ROCHE LTD.
  • TABLE 45 Key Information - DexCom, Inc.
  • TABLE 46 Key information - Novo Nordisk A/S
  • TABLE 47 Key Information - Sanofi S.A.
  • TABLE 48 Key Information - Zealand Pharma A/S
  • TABLE 49 key Information - B. Braun Melsungen AG
  • TABLE 50 Key Information - Bayer AG
  • TABLE 51 Key Information - Abbott Laboratories
  • TABLE 52 Key Information --Ypsomed AG
  • TABLE 53 Key Information - Arkray, Inc.

List of Figures

  • FIG 1 Methodology for the research
  • FIG 2 KBV Cardinal Matrix
  • FIG 3 Key Leading Strategies: Percentage Distribution (2018-2022)
  • FIG 4 Key Strategic Move: (Partnerships, collaborations and agreements : 2018, oct - 2022, may) Leading Players
  • FIG 5 Recent strategies and developments: F. Hoffmann-La Roche Ltd.
  • FIG 6 Recent strategies and developments: DexCom, Inc.
  • FIG 7 Recent strategies and developments: Novo Nordisk A/S
  • FIG 8 Recent strategies and developments: Sanofi S.A.
  • FIG 9 Recent strategies and developments: Zealand Pharma A/S
  • FIG 10 Recent strategies and developments: Arkray, Inc.
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!